Jae-Cheol Jo

23PUBLICATIONS
75CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 18, 2026
Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study.

|Dec 10, 2025
Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study.

Rakesh Popat, Meral Beksac, Meletios A Dimopoulos

|May 30, 2024
Immunophenotypic classification regarding prognosis in peripheral T cell lymphoma, NOS, and nodal T follicular helper T cell lymphoma, angioimmunoblastic-type.

Soyeon Choi, Jae-Cheol Jo, Yoo Jin Lee

|Aug 08, 2023
LIGHT (TNFSF14) promotes the differentiation of human bone marrow-derived mesenchymal stem cells into functional hepatocyte-like cells.

Sook-Kyoung Heo, Ho-Min Yu, Do Kyoung Kim

|Jun 26, 2023
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation.

Dong Won Baek, Joon Ho Moon, Jae Hoon Lee

|Apr 20, 2023
Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea.

Sang Hyuk Park, Hyun-Ki Kim, Joseph Jeong

Pageof 4

Frequent Collaborators

4 joint publications

Yoo Jin Lee

3 joint publications

Won Seog Kim

3 joint publications

Deok-Hwan Yang

2 joint publications

Hawk Kim